My primary concern is safety
Composition & Format Per vial composition: TB-500 10 mg + BPC-157 10 mg + KPV 10 mg + GHK-Cu 50 mg (80 mg total) Peptide roles (research context): TB-500 and BPC-157 are widely referenced in tissue repair and recovery models
Losing weight can also contribute to weakened bones
Temporary soreness, redness, or bruising at the injection site Mild itching or swelling at the site Occasional nausea, headache, or lightheadedness shortly after injection Allergic reaction (uncommon) Infection at the injection site if sterile technique is compromised Nutrient imbalance with prolonged, unsupervised use particularly relevant for patients with kidney disease The FDA has warned against unapproved injectable products marketed for fat reduction, citing risks including infection, scarring, and skin deformities
Accessibility improvements, including readable fonts, high-contrast themes, and intuitive menus, can further reduce friction